Drawing for AMPORE

USPTO serial 79405716

AMPORE

Reviewed by CopyMark Law Group

Reg. 7741734Status 700Registered
Filing date
Status date
Registration date
Apr 1, 2025
Examiner
OAKES, ANNA JENNIE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with AMPORE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christina M. Licursi

Christina M. Licursi Wolf Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210United States

Goods and services

ClassDescriptionStatusFirst use
010Medical and veterinary testing and diagnostic apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; electrowetting devices for medical and veterinary purposes; apparatus and instruments for automating the extraction and preparation of test samples for medical and veterinary purposes; portable medical and veterinary testing and diagnostic apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; diagnostic apparatus for medical or veterinary purposes for pregnancy testing, and for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; portable diagnostic apparatus for medical or veterinary purposes for pregnancy testing, and for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; testing apparatus for medical or veterinary purposes for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; portable testing apparatus for medical or veterinary purposes for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; cartridges for test samples, for medical purposes; reaction units containing chemical reagents, namely, reaction systems for medical testing purposes; Nanopore sensing devices for medical and veterinary purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 19, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 2, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 2, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Nov 15, 2025FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 17, 2025XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Oct 17, 2025XXCRGENERIC MADRID TRANSACTION CREATED—
Jul 2, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 1, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 1, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 11, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 11, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 5, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 17, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 10, 2025RFNTREFUSAL PROCESSED BY IB—
Jan 8, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 8, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 8, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 22, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 22, 2024RFRRREFUSAL PROCESSED BY MPU—
Dec 11, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 10, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 19, 2024DOCKASSIGNED TO EXAMINER—
Oct 16, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 16, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 3, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance